A Powerful CRISPR/Cas9-Based Method for Targeted Transcriptional Activation.

Katayama, Shota; Moriguchi, Tetsuo; Ohtsu, Naoki; Kondo, Toru

Katayama, Shota; Moriguchi, Tetsuo; Ohtsu, Naoki; Kondo, Toru.

Katayama S; Graduate School of Medicine, Hokkaido University, Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0815, Japan. shotakatayama.bio@gmail.com.
Moriguchi T; Graduate School of Medicine, Hokkaido University, Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0815, Japan.
Ohtsu N; Graduate School of Medicine, Hokkaido University, Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0815, Japan.
Kondo T; Graduate School of Medicine, Hokkaido University, Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0815, Japan. tkondo@igm.hokudai.ac.jp.

Angew Chem Int Ed Engl ; 55(22): 6452-6, 2016 05 23.

Article en En | MEDLINE | ID: mdl-27079176

Asunto(s)

Sistemas CRISPR-Cas/genética; Proteína Homeótica Nanog/genética; Factor de Transcripción 2 de los Oligodendrocitos/genética; Línea Celular; Células HEK293; Humanos; Proteína Homeótica Nanog/metabolismo; Factor de Transcripción 2 de los Oligodendrocitos/metabolismo; Activación Transcripcional/genética

Palabras clave

CRISPR/Cas9; epigenetics; gene expression; gene technology; synthetic biology

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas / Proteína Homeótica Nanog / Factor de Transcripción 2 de los Oligodendrocitos Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google